# Ducentis BioTherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ducentis-biotherapeutics

- Industry: Biotechnology
- Headquarters: Oxford, UK
- Website: www.ducentisbio.com
- Total disclosed funding: $3.8M
- Latest round: Seed (Apr 4, 2019)
- Investors on record: 3

## About

Ducentis BioTherapeutics Ltd. specializes in developing innovative biopharmaceutical therapies aimed at addressing unmet medical needs, focusing on effective treatment solutions in the healthcare sector.Founded in 2015 in Oxford, UK, Ducentis BioTherapeutics Ltd. develops biopharmaceuticals for unmet medical needs. The company completed its most recent funding round, a Trade Sale, in September 2022, raising USD 16.00 mn from Arcutis Biotherapeutics, Inc. They have executed a total of 4 deals to date.Ducentis BioTherapeutics Ltd. focuses on developing advanced biotherapeutics. Their products are designed to target specific medical conditions, enhancing treatment efficacy. The company tailors its offerings to meet the needs of healthcare providers and patients, ensuring that they address critical health challenges effectively.Ducentis BioTherapeutics Ltd. reported an EBITDA of USD -59,953.70 in 2015. Their revenue model primarily focuses on strategic partnerships and commercial agreements with firms in the biopharmaceutical industry, facilitating their growth within the market.In September 2022, Arcutis Biotherapeutics, Inc. acquired Ducentis BioTherapeutics Ltd. for USD 16.00 mn cash upfront, with potential future payments tied to development and commercial success. This acquisition is expected to bolster Ducentis's capabilities in advanced biopharmaceutical development, enhancing their market presence.

## Funding rounds

- Seed, Apr 4, 2019, $2.7M — LifeArc
- Angel, Mar 7, 2017, $0.9M — Oxford Technology Management, Capital Cell Investors
- Seed, Jul 9, 2015, $0.1M — Oxford Technology Management

## Investors

- Oxford Technology Management (https://capitalatlas.ai/funds/oxford-technology-management) — Seed, Angel
- Capital Cell Investors — Angel
- LifeArc (https://capitalatlas.ai/funds/lifearc) — Seed